NASDAQ: ERAS - Erasca, Inc.

Yield per half year: -39.25%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Erasca, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Erasca, Inc.

Erasca, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на обнаружении, разработке и коммерциализации методов лечения пациентов с раком, управляемым путем RAS / MAPK. Его главные кандидаты включают ERAS-007, пероральный ингибитор ERK1 / 2 для лечения NSCLC, колоректального рака и острого миелоидного лейкоза; и ERAS-601, пероральный ингибитор SHP2 для пациентов с запущенными или метастатическими солидными опухолями. Компания была зарегистрирована в 2018 году, ее штаб-квартира находится в Сан-Диего, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-07-16
ISIN US29479A1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт http://www.erasca.com
Цена ао 2.06
Change price per day: -2.01% (1.99)
Change price per week: +5.41% (1.85)
Change price per month: -24.12% (2.57)
Change price per 3 month: -26.14% (2.64)
Change price per half year: -39.25% (3.21)
Change price per year: +15.38% (1.69)
Change price per 3 year: -83.1% (11.54)
Change price per 5 year: 0% (1.95)
Change price per 10 year: 0% (1.95)
Change price per year to date: -23.83% (2.56)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.03 9
P/E 0 0
EV/EBITDA -2.1 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -31.63 0
ROE, % -39.48 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4054 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 833.15 10
Yield EPS, % 362.55 10
Total: 8
More

Institutions Volume Share, %
Arch Venture Management, Llc 11 6.38
Blackrock Inc. 7 4.03
Armistice Capital, LLC 6 3.56
Artal Group S.A. 5 2.72
Vanguard Group Inc 4 2.5
Prosight Management, LP 4 2.11
Ah Capital Management, L.L.C. 3 1.65
PFM Health Sciences, LP 3 1.46
Sio Capital Management, LLC 2 1.4
Bank of America Corporation 2 1.27

ETF Share, % Profitability for 1 year, % Dividends, %
Range Cancer Therapeutics ETF 1.89878 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 1.04981 63.04 0.33
iShares Micro-Cap ETF 0.12998 17.09 1.54048
Future Tech ETF 0.07922 426.34 0.8416
Principal Healthcare Innovators ETF 0.07922 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.07437 28.58 0.8565
Avantis U.S Small Cap Equity ETF 0.05731 27.77 1.68271
Goldman Sachs Innovate Equity ETF 0.05299 29.66 1.20987
ProShares Ultra Nasdaq Biotechnology 0.0499 51.7 0.85651
Schwab U.S. Small-Cap ETF 0.01407 17.47 1.51433
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
Fidelity MSCI Health Care Index ETF 0.00719 3 1.46057
ProShares UltraPro Russell2000 0.00704 89.82 1.47873
SPDR Portfolio MSCI Global Stock Market ETF 0.00322 17.99 2.19607
ProShares Hedge Replication ETF 0.00199 5.92 1.47892
Dimensional U.S. Targeted Value ETF 0.00192 26.01 1.93487
iShares Russell 3000 ETF 0.00132 24.83 1.43482
Dimensional U.S. Equity ETF 0.00096 31.53 1.3557
Schwab U.S. Broad Market ETF 0.00089 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00048 30.98 1.40618
Avantis U.S. Equity ETF 0.0004 23.04 1.59151
Dimensional U.S. Core Equity 2 ETF 0.00032 30.76 1.47098
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. David M. Chacko M.D. CFO & Chief Business Officer 616.76k 1984 (41 year)
Dr. Michael D. Varney Ph.D. Chairman of Research & Development, Scientific Advisory Board Member and Director 83.26k 1958 (67 years)
Dr. Nik Chetwyn Ph.D. Chief Operating Officer N/A
Dr. Lisa Tesvich-Bonora Ph.D. Chief People Officer N/A
Dr. Robert Shoemaker Ph.D. Senior Vice President of Research N/A 1981 (44 years)
Dr. Jonathan E. Lim M.D. Co-Founder, Chairman & CEO 940.32k 1972 (53 years)
Ms. Chandra D. Lovejoy M.S. Chief Regulatory Affairs Officer N/A 1971 (54 years)
Dr. Shannon R. Morris M.D., Ph.D. Chief Medical Officer N/A 1970 (55 years)
Mr. Brian L. Baker CPA, M.S. Senior Vice President of Finance N/A 1967 (58 years)
Mr. Ebun S. Garner Esq., J.D. General Counsel & Corporate Secretary 1972 (53 years)

Address: United States, San Diego, CA , 10835 Road to the Cure - open in Google maps, open in Yandex maps
Website: http://www.erasca.com